Molecular Partners AG Operating Expenses Growth & History (MOLN)

Molecular Partners AG's operating expenses was CHF58.1M for fiscal 2025.

View full Molecular Partners AG company overview

Molecular Partners AG annual operating expenses history

Molecular Partners AG annual operating expenses

Fiscal yearPeriod endedOperating expensesChangeGrowth
20252025-12-31CHF58.1M−CHF8.1M−12.18%
20242024-12-31CHF66.2M−CHF2.0M−2.87%
20232023-12-31CHF68.1M−CHF4.8M−6.63%
20222022-12-31CHF73.0M−CHF185,000−0.25%
20212021-12-31CHF73.2MCHF5.5M+8.13%
20202020-12-31CHF67.7MCHF10.6M+18.63%
20192019-12-31CHF57.0M

Molecular Partners AG operating expenses trends

Over the last five fiscal years, Molecular Partners AG's operating expenses decreased from CHF67.7M to CHF58.1M, a change of −CHF9.5M. The latest reported quarter, Q2 2026, shows CHF13.6M.

About the metric

What operating expenses mean

Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.

Calculation and source

SEC-reported and calculated operating expenses

TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Molecular Partners AG source filings ↗

Community posts

It’s quiet here.

No posts about MOLN yet. Start the conversation.

Write the first post